| Dr Kathleen Mcgowan, | |
|
100 E Idaho St, Suite 400, Boise, ID 83712-6223 | |
| (208) 345-5250 | |
| (208) 345-2364 |
| Full Name | Dr Kathleen Mcgowan |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 100 E Idaho St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730280017 | NPI | - | NPPES |
| 003838300 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | M4790 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathleen Mcgowan, 100 E Idaho St, Suite 400, Boise, ID 83712-6223 Ph: (208) 345-5250 | Dr Kathleen Mcgowan, 100 E Idaho St, Suite 400, Boise, ID 83712-6223 Ph: (208) 345-5250 |
News Archive
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
Research shows that people with low incomes are more likely to develop kidney failure and less likely to receive a living donor kidney transplant than people of other socioeconomic classes.
Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.
Sucampo Pharmaceuticals, Inc. and Abbott today announced positive top-line data from a 48-week phase 3 long-term safety and efficacy clinical trial of lubiprostone in Japanese patients with chronic idiopathic constipation (CIC). The trial demonstrated that lubiprostone was safe and well-tolerated.
› Verified 4 days ago
Cristin C Slater, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 111 Main St, #100, Boise, ID 83702 Phone: 208-342-5900 Fax: 208-342-2088 | |
Maryalice Lopez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 333 N 1st St Ste 240, Boise, ID 83702 Phone: 208-338-8900 | |
Martha H Lund, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6140 Curtisian Ave, Suite 100, Boise, ID 83704 Phone: 208-367-4224 Fax: 208-367-7806 | |
Dr. B Kerry Lowder, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Suite 400, Boise, ID 83712 Phone: 208-345-5250 Fax: 208-345-2364 | |
Dr. Michael F Koszalka Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 N 1st St Ste 150, Boise, ID 83702 Phone: 208-381-3088 | |
Dr. Juliana L Digiosia, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1072 N Liberty St, Suite 100, Boise, ID 83704 Phone: 208-302-1200 Fax: 208-302-1255 | |
Kathleen C. Keating, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St Ste 400, Boise, ID 83712 Phone: 208-345-5250 |